An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Frazier Life Sciences Adds Highly Experienced Biopharmaceutical Executive to Team
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Menlo Park, Calif. — Frazier Life Sciences appointed Angie You, Ph.D., as Senior Advisor following her tenure as CEO of Amunix Pharmaceuticals, acquired by Sanofi for up to $1.225 billion. Dr. You previously held key roles at Sierra Oncology (NASDAQ: SRRA), where she contributed to a successful IPO and pipeline development. With a Ph.D. in Biochemistry from Harvard, her extensive experience in biopharmaceuticals will aid Frazier in identifying investment opportunities. Frazier Life Sciences has raised over $2.1 billion and supported 61 IPOs or M&As since 2005.
Positive
Angie You's appointment as Senior Advisor enhances Frazier's expertise in biopharmaceuticals.
Dr. You's track record includes a successful IPO for Sierra Oncology and strategic development of its pipeline.
Frazier Life Sciences has raised over $2.1 billion, showcasing its strong financial backing.
Negative
None.
MENLO PARK, Calif.--(BUSINESS WIRE)--
Frazier Life Sciences announced the addition of Angie You, Ph.D. as a Senior Advisor. She most recently served as Chief Executive Officer of Amunix Pharmaceuticals Inc. until its acquisition by Sanofi for up to $1.225 billion.
Prior to joining Amunix, Dr. You served as Chief Business & Strategy Officer and Head of Commercial at Sierra Oncology (NASDAQ: SRRA), a publicly listed hematology and oncology drug development company, where she helped the company through a successful initial public offering. She also led the company’s strategic and transactional business and commercial efforts, including building its robust pipeline through acquisition and licensing of several product assets.
Prior to Sierra, Dr. You served as Chief Business Officer of Aragon Pharmaceuticals, a private oncology drug discovery and development company, where she was responsible for finance, operations, human resources, and business development. At Aragon, she helped secure several rounds of financing as well as leading the business development process that resulted in the company’s acquisition by Johnson & Johnson.
In previous roles, Dr. You served as Chief Business Officer at Synosia Therapeutics and Ren Pharmaceuticals. Before joining Ren Pharmaceuticals, she focused on new company formation at Venrock Ventures.
Dr. You earned a Ph.D. in Biochemistry from Harvard University and a B.A. in Chemistry from Harvard College.
“We are excited about being able to continue to work with Angie after the sale of Amunix,” said Managing Partner Jamie Topper. “She is a highly experienced biopharmaceutical executive who will help us identify and evaluate investment opportunities.”
About Frazier Life Sciences
Frazier Life Sciences invests globally in private and publicly-traded companies that discover, develop, and commercialize innovative biopharmaceuticals. Frazier Life Sciences funds comprise over $2.1 billion in capital raised (as of January 2022), including venture funds focusing on company creation and private companies, and a public fund focused on small and mid-cap public companies. Since 2005, 61 Frazier Life Sciences portfolio companies, many of which were created or seeded by Frazier, have completed IPOs or M&As. The Frazier Life Sciences team consists of over 40 professionals with deep expertise in biopharmaceuticals, primarily located in Menlo Park, California (headquarters), San Diego, Seattle, Boston, New York, and London.
